Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biovie (BIVI) Cash & Equivalents: 2013-2025

Historic Cash & Equivalents for Biovie (BIVI) over the last 9 years, with Mar 2025 value amounting to $23.2 million.

  • Biovie's Cash & Equivalents fell 23.68% to $23.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $23.2 million, marking a year-over-year decrease of 23.68%. This contributed to the annual value of $17.5 million for FY2025, which is 26.42% down from last year.
  • Biovie's Cash & Equivalents amounted to $23.2 million in Q1 2025, which was down 4.94% from $24.4 million recorded in Q4 2024.
  • Biovie's 5-year Cash & Equivalents high stood at $45.7 million for Q4 2022, and its period low was $11.4 million during Q1 2021.
  • Over the past 3 years, Biovie's median Cash & Equivalents value was $23.2 million (recorded in 2025), while the average stood at $26.2 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 305,452.03% in 2021, then plummeted by 55.85% in 2023.
  • Over the past 5 years, Biovie's Cash & Equivalents (Quarterly) stood at $30.4 million in 2021, then spiked by 50.53% to $45.7 million in 2022, then crashed by 55.85% to $20.2 million in 2023, then rose by 20.82% to $24.4 million in 2024, then declined by 23.68% to $23.2 million in 2025.
  • Its last three reported values are $23.2 million in Q1 2025, $24.4 million for Q4 2024, and $20.0 million during Q3 2024.